Cite

    Hersh, C. et al. (2017). Comparative efficacy and discontinuation of dimethyl fumarate and fingolimod in clinical practice at 24-month follow-up. Multiple sclerosis journal, experimental, translational and clinical. 3 (3), p. . [Online].